Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1977 1
1979 1
1980 1
1981 3
1982 2
1983 2
1984 3
1985 4
1986 4
1987 2
1988 1
1989 6
1990 3
1991 6
1992 5
1993 17
1994 3
1995 6
1996 3
1997 5
1998 7
1999 8
2000 7
2001 20
2002 13
2003 17
2004 10
2005 12
2006 18
2007 16
2008 1
2009 6
2010 7
2011 3
2012 4
2013 4
2014 10
2015 6
2016 11
2017 20
2018 16
2019 12
2020 14
2021 20
2022 16
2023 13
2024 21
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

360 results

Results by year

Filters applied: . Clear all
Page 1
Predictors and consequences of intellectual humility.
Porter T, Elnakouri A, Meyers EA, Shibayama T, Jayawickreme E, Grossmann I. Porter T, et al. Among authors: shibayama t. Nat Rev Psychol. 2022;1(9):524-536. doi: 10.1038/s44159-022-00081-9. Epub 2022 Jun 27. Nat Rev Psychol. 2022. PMID: 35789951 Free PMC article. Review.
Immuno-genomic analysis reveals eosinophilic feature and favorable prognosis of female non-smoking esophageal squamous cell carcinomas.
Okawa Y, Sasagawa S, Kato H, Johnson TA, Nagaoka K, Kobayashi Y, Hayashi A, Shibayama T, Maejima K, Tanaka H, Miyano S, Shibahara J, Nishizuka S, Hirano S, Seto Y, Iwaya T, Kakimi K, Yasuda T, Nakagawa H. Okawa Y, et al. Among authors: shibayama t. Cancer Lett. 2024 Jan 28;581:216499. doi: 10.1016/j.canlet.2023.216499. Epub 2023 Nov 25. Cancer Lett. 2024. PMID: 38013050 Free article.
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations.
Ninomiya T, Ishikawa N, Kozuki T, Kuyama S, Inoue K, Yokoyama T, Kanaji N, Yasugi M, Shibayama T, Aoe K, Ochi N, Fujitaka K, Kodani M, Ueda Y, Watanabe K, Bessho A, Sugimoto K, Oze I, Hotta K, Kiura K. Ninomiya T, et al. Among authors: shibayama t. Lung Cancer. 2023 Oct;184:107349. doi: 10.1016/j.lungcan.2023.107349. Epub 2023 Aug 19. Lung Cancer. 2023. PMID: 37651927 Clinical Trial.
Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune.
Oguma T, Ishiguro T, Kamei K, Tanaka J, Suzuki J, Hebisawa A, Obase Y, Mukae H, Tanosaki T, Furusho S, Kurokawa K, Watai K, Matsuse H, Harada N, Nakamura A, Shibayama T, Baba R, Fukunaga K, Matsumoto H, Ohba H, Sakamoto S, Suzuki S, Tanaka S, Yamada T, Yamasaki A, Fukutomi Y, Shiraishi Y, Toyotome T, Fukunaga K, Shimoda T, Konno S, Taniguchi M, Tomomatsu K, Okada N, Asano K; Japan ABPM Research Program. Oguma T, et al. Among authors: shibayama t. Clin Transl Allergy. 2024 Jan;14(1):e12327. doi: 10.1002/clt2.12327. Clin Transl Allergy. 2024. PMID: 38282191 Free PMC article.
Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma.
Shibayama T, Hayashi A, Toki M, Kitahama K, Ho YJ, Kato K, Yamada T, Kawamoto S, Kambayashi K, Ochiai K, Gondo K, Okano N, Melchor JP, Iacobuzio-Donahue CA, Sakamoto Y, Hisamatsu T, Shibahara J. Shibayama T, et al. Sci Rep. 2024 Jul 6;14(1):15598. doi: 10.1038/s41598-024-65900-w. Sci Rep. 2024. PMID: 38971768 Free PMC article.
Giant multilocular prostatic cystadenoma.
Nakamura Y, Shida D, Shibayama T, Yoshida A, Matsui Y, Shinoda Y, Iwata S, Kanemitsu Y. Nakamura Y, et al. Among authors: shibayama t. World J Surg Oncol. 2019 Feb 26;17(1):42. doi: 10.1186/s12957-019-1579-7. World J Surg Oncol. 2019. PMID: 30808350 Free PMC article.
Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease.
Gono T, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Ikeda K, Kirino Y, Sugiyama Y, Tanino Y, Nunokawa T, Kaneko Y, Sato S, Asakawa K, Ukichi T, Kaieda S, Naniwa T, Okano Y, Kuwana M; the Multicenter Retrospective Cohort of Japanese Patients with Myositis-Associated ILD (JAMI) Investigators. Gono T, et al. Arthritis Rheumatol. 2021 Apr;73(4):677-686. doi: 10.1002/art.41566. Epub 2021 Feb 22. Arthritis Rheumatol. 2021. PMID: 33118321
360 results